Princess Alexandra Hospital; Oncology Department
About Princess Alexandra Hospital; Oncology Department
The Princess Alexandra Hospital NHS Trust serves a population of 258,000 and provides healthcare services to the communities of Harlow and the surrounding areas.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Clinical Trials at Princess Alexandra Hospital; Oncology Department
During the past decade, Princess Alexandra Hospital; Oncology Department conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Patients With PIK3CA-Mutant, Hormone Receptor-Positive, Her2-Negative, Locally Advanced or Metastatic Breast Cancer
2020-01-29
2025-09-19
Recruiting
400
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
2020-11-27
2023-11-27
Active, not recruiting
303
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Princess Alexandra Hospital; Oncology Department
According to Clinical.Site data, the most researched conditions in "Princess Alexandra Hospital; Oncology Department" are
"Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials) and "Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Princess Alexandra Hospital; Oncology Department" in a lesser frequency.
Clinical Trials Intervention Types at Princess Alexandra Hospital; Oncology Department
Most popular intervention types in "Princess Alexandra Hospital; Oncology Department" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Fulvestrant" (1 trials), "Fulvestrant or an Aromatase Inhibitor (Physician Choice)" (1 trials), "Giredestrant" (1 trials), "Herceptin" (1 trials) and "Inavolisib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Princess Alexandra Hospital; Oncology Department
The vast majority of trials in "Princess Alexandra Hospital; Oncology Department" are
3 trials for "All" genders.
Clinical Trials Status at Princess Alexandra Hospital; Oncology Department
Currently, there are NaN active trials in "Princess Alexandra Hospital; Oncology Department".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Princess Alexandra Hospital; Oncology Department,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Princess Alexandra Hospital; Oncology Department, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".